Related Experiment Video
Updated: Dec 11, 2025
07:27
How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
Published on: August 19, 2020
12.2K
Hyperbilirubinemia in pediatrics: Evaluation and care
Pramodha Muniyappa1, Darah Kelley2
1Division of Pediatric Gastroenterology and Nutrition, Dayton Children's Hospital, Dayton, OH 45404, United States.
Current Problems in Pediatric and Adolescent Health Care
|August 24, 2020
Summary
This review covers the evaluation and diagnosis of hyperbilirubinemia in children, from newborns to older kids. It uses the latest guidelines from pediatric gastroenterology societies to differentiate causes from benign to severe.
Area of Science:
- Pediatric Gastroenterology
- Neonatology
- Clinical Diagnostics
Background:
- Hyperbilirubinemia is a frequent lab finding in pediatric patients, particularly neonates.
- It encompasses a spectrum of conditions, ranging from harmless physiological variations to critical systemic diseases.
- Accurate diagnosis is crucial for appropriate management and preventing complications.
Purpose of the Study:
- To provide a comprehensive overview of hyperbilirubinemia evaluation in infants and children.
- To outline differential diagnoses for pediatric hyperbilirubinemia.
- To present the latest evidence-based guidelines for managing this condition.
Main Methods:
- Literature review of recent guidelines from major pediatric gastroenterology organizations.
- Synthesis of diagnostic approaches for hyperbilirubinemia in different age groups.
- Analysis of differential diagnoses based on clinical presentation and laboratory findings.
Main Results:
- Established guidelines offer a structured approach to evaluating pediatric hyperbilirubinemia.
- Key factors in diagnosis include age of onset, bilirubin levels, and clinical signs.
- A systematic workup helps distinguish benign causes from serious underlying pathologies.
Conclusions:
- A thorough evaluation based on current guidelines is essential for diagnosing pediatric hyperbilirubinemia.
- Timely and accurate diagnosis facilitates appropriate treatment and improves patient outcomes.
- This review serves as a practical resource for clinicians managing hyperbilirubinemia in children.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
110
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
110
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
131
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
147
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
147
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
104
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
104
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
174
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
174
01:29Drug Dosing: Infants and Children
151
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
151